Our Management////////////////////////

Opher Shapira, PhD

Opher Shapira, PhD

CEO

Opher is an experienced entrepreneur and manager with close to 20 years of experience in the medical industry. Opher was the founder, President and CEO of BioView Ltd. (Public TASE).  Opher has a PhD in Physics from Yale University and a B.Sc. in Physics and Computer Sciences from Tel Aviv University.

Adam Wasserstrom, PhD

Adam Wasserstrom, PhD

VP  Bioinformatics and Co-founder

Adam holds a Ph.D. in Life Sciences from the Weizmann Institute, and a B.A in Computer Sciences cum laude and Music from Tel-Aviv University. He specializes in integration of computer science tools in biological applications, and is an author of 9 scientific papers and inventor of 5 patents.

Danny Frumkin, PhD

Danny Frumkin, PhD

VP Biochemistry and Co-founder

Danny completed his Ph.D. in Life Sciences from the Weizmann Institute, B.Sc. In Medical Sciences from Tel-Aviv University. Specializes in medical applications of DNA biochemistry. Author of 10 scientific papers and inventor of 5 patents.

Shmulik Adler, MSc

Shmulik Adler, MSc

VP of Regulatory, Quality and Clinical Affairs

Shmulik has over 14 years of experience as senior regulatory affairs, clinical trials and reimbursement manger. Prior to joining Nucleix, Shmulik served as VP of Business development and reimbursement for Brainsway (TASE:BRIN).  Prior to this Shmulik led the clinical department of a boutique CRO in which he managed several clinical trials which led to the FDA clearance and CE approval of various medical devices. Shmulik holds an M.Sc in Pharmacology and physiology from the Tel Aviv University.

Aharona Shuali, MD, MBA

Aharona Shuali, MD, MBA

VP Medical

Aharona holds an MD from the Hebrew University in Jerusalem, and an MBA from Tel Aviv University. She has more than 10 years’ experience in development and commercialization of oncology-targeted products in pharmaceutical and medical device industries.

Ricardo A.J. ten Velden

Ricardo A.J. ten Velden

VP Sales & Marketing

Ricardo has over 30 years of experience in business development and sales & marketing. He achieved a sustained record of success in the Life Sciences industry e.g. innovative (lifestyle) prescription drugs, generics, biologics, biosimilars, and medical devices. He started his career in Pharmaceuticals and later transitioned to molecular diagnostics. Before joining Nucleix he served as the Director Sales & Marketing EMEA of MDxHealth (ENX:MDXH), a multinational healthcare company that provides actionable genomic information to personalize the diagnosis and treatment of cancer. Prior to this he was commercial leader for international markets in companies such as Avery Dennison, Merck Sharp & Dohme and Organon (AkzoNobel). For Organon he worked more than six years as an expat in Italy. Back in the Netherlands he set up the Benelux subsidiary of Hikma Pharmaceuticals (LON:HIK). Ricardo studied law at the VU University Amsterdam and marketing at the Netherlands Institute of Marketing.